Zacks Investment Research on MSN
BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now?
Cardiovascular disease is the biggest driver of health care spending in most countries, creating more opportunities for ...
Cambridge Heartwear Ltd., a trailblazer in medical device innovation and AI technology, is transforming the cardiovascular ...
The Centers for Medicare and Medicaid Services (CMS) has provided a major reimbursement update for cardiac ablation ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardio Flow, Inc., a privately held commercial-stage medical device company and developer of minimally invasive devices to treat peripheral artery disease (PAD), is ...
TipRanks on MSN
HeartBeam (NASDAQ: BEAT) Poised in the Future of Cardiac Care with Breakthrough Technology
Austin, Texas, United States, November 20th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT) is on the verge of transforming how ...
IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. examines pulsed field ablation technologies for atrial fibrillation and the role wearable monitoring devices can play in women’s cardiovascular health in ...
According to DataM Intelligence, the U.S. Software as a Medical Device (SaMD) Market Size reached USD 205.12 million in 2024 ...
Cardiovascular disease accounted for 12% of total U.S. health expenditures in 2019 to 2020, more than any major diagnostic group, according to a 2024 report from the American Heart Association.
HeartBeam (NASDAQ: BEAT) is on the verge of transforming how atrial fibrillation ("AF") is detected and managed with its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback